2026 Co-Op, Maintenance Excellance
Description
The Maintenance Excellence Co-Op will assist with Defense-in-Depth (DiD) Analysis reporting activities. This involves compiling, analyzing, and preparing DiD documentation and presentations to support reliability, risk mitigation, and asset performance initiatives, aligning with Reliability-Centered Maintenance (RCM) and Failure Modes and Effects Analysis (FMEA) methodologies. The co-op position runs from July 11th to December 13th, 2026.
What We're Looking For
Compile and document Defense-in-Depth findings from facilitated workshops and working sessions,Support DiD assessments leveraging RCM and FMEA principles, including failure mode identification and risk evaluation,Draft and maintain Detailed DiD Analysis reports in alignment with approved frameworks, templates, and reliability methodologies,Prepare Kick-off decks defining system scope, objectives, roles, and timelines,Develop Executive Summary decks summarizing risks, failure modes, mitigation strategies, and key actions,Support preliminary risk rating activities (likelihood, severity, detectability) under Engineering guidance,Track action items, assigned owners, and completion status resulting from DiD, RCM, and FMEA assessments,Prepare figures, tables, and visuals to support consistent and clear reporting,Support standardization and continuous improvement of DiD, RCM, and FMEA reporting tools and documentation
Ideal Candidate
Pursuing a degree in Engineering, Engineering Technology, Industrial Engineering, or a related technical discipline,Familiarity with reliability concepts such as RCM, FMEA, or risk-based maintenance methodologies preferred,Strong technical writing and documentation skills,Proficiency in Microsoft PowerPoint and Excel,Strong organizational skills and attention to detail,Ability to synthesize technical inputs into structured summaries
Minimum Education
Currently pursuing a Bachelor's Degree in Engineering or related technical discipline
Hard Skills
Soft Skills
Work Hours
Full-time, July 11th - December 13th, 2026
Benefits
Special Commitments
Must hold current US work authorization without requiring future sponsorship,Only individuals who qualify as U.S. persons (citizens, permanent residents, asylees, or refugees) are eligible due to export control regulations
About the Company
Moderna, Inc.
Moderna is a biotechnology company pioneering a new class of medicines made of messenger RNA (mRNA). The company's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases.
We respect your privacy
BerryMap uses cookies to provide essential features, analyze usage, and improve your experience. You can customize your preferences below.